Details of Drug

Drug General Information (ID: D1723)
Drug Name	Zinc chloride
Drug Type	Small molecule
Drug Synonymous	Zinc Chloride In Plastic Container Click to Show/Hide
Disease Class	CA00: Nasopharyngitis
Therapeutic Class	Minerals And Electrolytes
Structure
Structure	3D Structure		2D Structure
Formula	Cl2Zn
InChI	1S/2ClH.Zn/h2*1H;/q;;+2/p-2
InChIKey	JIAARYAFYJHUJI-UHFFFAOYSA-L
Canonical SMILES	Cl[Zn]Cl
External Link
	Pubchem ID	5727
	CAS Number	7646-85-7
	TTD ID	D05ELV

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM110 Antagonize the effects of immunosuppressants
Relation Graph

Full list of drugs interacting with Zinc chloride
Affected gastrointestinal absorption
	Complex formation					Drug Num: 14
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0563		Elvitegravir	C23H23ClFNO5	5277135	Major		Inter Info	[1]
D1377		Raltegravir	C20H21FN6O5	54671008	Major		Inter Info	[1]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]
D0441		Demeclocycline	C21H21ClN2O8	54680690	Moderate		Inter Info	[34], [35], [36], [37], [38]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]
D1070		Minocycline	C23H27N3O7	54675783	Moderate		Inter Info	[34], [35], [36], [37], [38]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[15], [16], [29]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33]
D1175		Omadacycline	C29H40N4O7	54697325	Moderate		Inter Info	[35], [37], [38]
D1209		Oxytetracycline	C22H24N2O9	54675779	Moderate		Inter Info	[35], [37], [38]
D1445		Sarecycline	C24H29N3O8	54681908	Moderate		Inter Info	[34], [35], [36], [37], [38]
D1564		Tetracycline	C22H24N2O8	54675776	Moderate		Inter Info	[34], [35], [36], [37], [38]
Pharmacodynamic antagonistic effects
	Antagonize the effects of immunosuppressants					Drug Num: 61
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0004		Abatacept	NA	NA	Minor		Inter Info	[39], [40], [41]
D0023		Adalimumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0032		Alefacept	NA	NA	Minor		Inter Info	[39], [40], [41]
D0085		Anakinra	C20H23N5O7S2	146171046	Minor		Inter Info	[39], [40], [41]
D0091		Antilymphocyte immunoglobulin (horse)	NA	NA	Minor		Inter Info	[39], [40], [41]
D0094		Antithymocyte immunoglobulin (rabbit)	NA	NA	Minor		Inter Info	[39], [40], [41]
D0136		Azathioprine	C9H7N7O2S	2265	Minor		Inter Info	[39], [40], [41]
D0146		Baricitinib	C16H17N7O2S	44205240	Minor		Inter Info	[39], [40], [41]
D0147		Basiliximab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0151		Belatacept	NA	NA	Minor		Inter Info	[39], [40], [41]
D0152		Belimumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0172		Betamethasone	C22H29FO5	9782	Minor		Inter Info	[39], [40], [41]
D0209		Brodalumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0215		Budesonide	C25H34O6	5281004	Minor		Inter Info	[39], [40], [41]
D0246		Canakinumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0304		Certolizumab pegol	NA	NA	Minor		Inter Info	[39], [40], [41]
D0402		Cyclosporine	C62H111N11O12	5284373	Minor		Inter Info	[39], [40], [41]
D0453		Dexamethasone	C22H29FO5	5743	Minor		Inter Info	[39], [40], [41]
D0540		Dupilumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0541		Durvalumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0553		Efalizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0614		Etanercept	NA	NA	Minor		Inter Info	[39], [40], [41]
D0629		Everolimus	C53H83NO14	6442177	Minor		Inter Info	[39], [40], [41]
D0736		Golimumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0747		Guselkumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0773		Hydrocortisone	C21H30O5	5754	Minor		Inter Info	[39], [40], [41]
D0801		Inebilizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0802		Infliximab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0875		Ixekizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0900		Leflunomide	C12H9F3N2O2	3899	Minor		Inter Info	[39], [40], [41]
D0996		Melphalan	C13H18Cl2N2O2	460612	Minor		Inter Info	[39], [40], [41]
D1041		Methylprednisolone	C22H30O5	6741	Minor		Inter Info	[39], [40], [41]
D1083		Mogamulizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1093		Muromonab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1094		Mycophenolate mofetil	C23H31NO7	5281078	Minor		Inter Info	[39], [40], [41]
D1095		Mycophenolic acid	C17H20O6	446541	Minor		Inter Info	[39], [40], [41]
D1111		Natalizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1162		Ocrelizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1176		Omalizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1332		Prednisolone	C21H28O5	5755	Minor		Inter Info	[39], [40], [41]
D1334		Prednisone	C21H26O5	5865	Minor		Inter Info	[39], [40], [41]
D1403		Rilonacept	NA	NA	Minor		Inter Info	[39], [40], [41]
D1416		Rituximab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1447		Sarilumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1454		Secukinumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1467		Siltuximab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1476		Sirolimus	C51H79NO13	5284616	Minor		Inter Info	[39], [40], [41]
D1526		Tacrolimus	C44H69NO12	445643	Minor		Inter Info	[39], [40], [41]
D1549		Temsirolimus	C56H87NO16	6918289	Minor		Inter Info	[39], [40], [41]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Minor		Inter Info	[39], [40], [41]
D1583		Tildrakizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1599		Tocilizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1600		Tofacitinib	C16H20N6O	9926791	Minor		Inter Info	[39], [40], [41]
D1628		Triamcinolone	C21H27FO6	31307	Minor		Inter Info	[39], [40], [41]
D1671		Ustekinumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1685		Vedolizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D0997		Melphalan flufenamide	C24H30Cl2FN3O3	9935639	Minor		Inter Info	[39], [40], [41]
D1113		Naxitamab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1410		Risankizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1448		Satralizumab	NA	NA	Minor		Inter Info	[39], [40], [41]
D1666		Upadacitinib	C17H19F3N6O	58557659	Minor		Inter Info	[39], [40], [41]

References
1	US National Library of Medicine "Guidelines for the use of antiretroviral agents in adults and adolescents with HIV.".
2	Akerele JO, Okhamafe AO "Influence of oral co-administered metallic drugs on ofloxacin pharmacokinetics." J Antimicrob Chemother 28 (1991): 87-94. [PMID: 1663108]
3	Allen A, Vousden M, Porter A, Lewis A "Effect of Maalox((R)) on the bioavailability of oral gemifloxacin in healthy volunteers." Chemotherapy 45 (1999): 504-11. [PMID: 10567782]
4	Campbell NR, Kara M, Hasinoff BB, Haddara WM, McKay DW "Norfloxacin interaction with antacids and minerals." Br J Clin Pharmacol 33 (1992): 115-6. [PMID: 1540482]
5	Frost RW, Lasseter KC, Noe AJ, Shamblen EC, Lettieri JT "Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin." Antimicrob Agents Chemother 36 (1992): 830-2. [PMID: 1503446]
6	Garrelts JC, Godley PJ, Peterie JD, Gerlach EH, Yakshe CC "Sucralfate significantly reduces ciprofloxacin concentrations in serum." Antimicrob Agents Chemother 34 (1990): 931-3. [PMID: 2360833]
7	Grasela TH Jr, Schentag JJ, Sedman AJ, et al "Inhibition of enoxacin absorption by antacids or ranitidine." Antimicrob Agents Chemother 33 (1989): 615-7. [PMID: 2751276]
8	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
9	Johnson RD, Dorr MB, Talbot GH, Caille G "Effect of Maalox on the oral absorption of sparfloxacin." Clin Ther 20 (1998): 1149-58. [PMID: 9916608]
10	Kamberi M, Nakashima H, Ogawa K, Oda N, Nakano S "The effect of staggered dosing of sucralfate on oral bioavailability of sparfloxacin." Br J Clin Pharmacol 49 (2000): 98-103. [PMID: 10671902]
11	Lehto P, Kivisto KT "Different effects of products containing metal ions on the absorption of lomefloxacin." Clin Pharmacol Ther 56 (1994): 477-82. [PMID: 7955811]
12	Lehto P, Kivisto KT "Effect of sucralfate on absorption of norfloxacin and ofloxacin." Antimicrob Agents Chemother 38 (1994): 248-51. [PMID: 8192452]
13	Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H "Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium." Antimicrob Agents Chemother 43 (1999): 1067-71. [PMID: 10223915]
14	Nix DE, Watson WA, Lener ME, et al "Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin." Clin Pharmacol Ther 46 (1989): 700-5. [PMID: 2598571]
15	Nix DE, Wilton JH, Ronald B, Distlerath L, Williams VC, Norman A "Inhibition of norfloxacin absorption by antacids." Antimicrob Agents Chemother 34 (1990): 432-5. [PMID: 2334155]
16	Noyes M, Polk RE "Norfloxacin and absorption of magnesium-aluminum." Ann Intern Med 109 (1988): 168-9. [PMID: 3382110]
17	Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, Schentag JJ "Sucralfate reduces the gastrointestinal absorption of norfloxacin." Antimicrob Agents Chemother 33 (1989): 99-102. [PMID: 2712548]
18	Polk RE, Helay DP, Sahai J, Drwal L, Racht E "Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers." Antimicrob Agents Chemother 33 (1989): 1841-4. [PMID: 2610494]
19	Product Information. Baxdela (delafloxacin). Melinta Therapeutics, Lincolnshire, IL.
20	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
21	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
22	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
23	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
24	Product Information. Trovan (trovafloxacin). Pfizer US Pharmaceuticals, New York, NY.
25	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
26	Sahai J, Healy DP, Stotka J, Polk RE "The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin." Br J Clin Pharmacol 35 (1993): 302-4. [PMID: 8471407]
27	Shimada J, Shiba K, Oguma T, et al "Effect of antacid on absorption of the quinolone lomefloxacin." Antimicrob Agents Chemother 36 (1992): 1219-24. [PMID: 1329615]
28	Spivey JM, Cummings DM, Pierson NR "Failure of prostatitis treatment secondary to probable ciprofloxacin-sucralfate drug interaction." Pharmacotherapy 16 (1996): 314-6. [PMID: 8820479]
29	Teng R, Dogolo LC, Willavize SA, Friedman HL, Vincent J "Effect of Maalox and omeprazole on the bioavailability of trovafloxacin." J Antimicrob Chemother 39 Suppl B (1997): 93-7. [PMID: 9222077]
30	Wadworth AN, Goa KL "Lomefloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use." Drugs 42 (1991): 1018-60. [PMID: 1724637]
31	Yuk JH "Ciprofloxacin levels when receiving sucralfate." J Am Geriatr Soc 262 (1989): 901. [PMID: 2754785]
32	Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
33	Deppermann KM, Lode H, Hoffken G, Tschink G, Kalz C, Koeppe P "Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid." Antimicrob Agents Chemother 33 (1989): 1901-7. [PMID: 2610502]
34	Gothoni G, Neuvonen PJ, Mattila M, Hackman R "Iron-tetracycline interaction: effect of time interval between the drugs." Acta Med Scand 191 (1972): 409-11. [PMID: 5031537]
35	Neuvonen PJ "Interactions with the absorption of tetracyclines." Drugs 11 (1976): 45-54. [PMID: 946598]
36	Penttila O, Hurme H, Neuvonen PJ "Effect of zinc sulphate on the absorption of tetracycline and doxycycline in man." Eur J Clin Pharmacol 9 (1975): 131-4. [PMID: 786686]
37	Product Information. Nuzyra (omadacycline). Paratek Pharmaceuticals, Inc., Boston, MA.
38	Product Information. Seysara (sarecycline). Allergan Inc, Irvine, CA.
39	Izzo AA, Ernst E "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs 61 (2001): 2163-75. [PMID: 11772128]
40	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
41	Pepping J "Echinacea." Am J Health Syst Pharm 56 (1999): 121-2

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence